Diacerein or a pharmaceutically acceptable salt thereof, monoacetylrhein or rhein, for use as an adjunctive therapy for type ii diabetes

摘要

The present invention provides methods of treating type II diabetes using combinations of diacerein or its derivatives with other antidiabetic agents. The methods may also allow improving glycemic control of type II diabetes patients and/or reducing side effects and/or cardiovascular risks of antidiabetic agents.